New study checks if VedAryo tames IBD Flare-Ups
Disease control
Completed
This study followed 150 people with inflammatory bowel disease (ulcerative colitis or Crohn's disease) who were given VedAryo (vedolizumab) to see if it helps control their condition and is safe. Participants received the drug by IV at the start, after 2 weeks, after 6 weeks, and…
Sponsor: AryoGen Pharmed Co. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC